KY0211
-
KY0211
structure -
-
CAS No:
1118807-13-8
-
Formula:
C18H17ClN2O3S
-
Chemical Name:
KY0211
-
Synonyms:
KY0211;KY02111;KY02111 /KY-02111;N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide;Benzenepropanamide, N-(6-chloro-2-benzothiazolyl)-3,4-dimethoxy-;KY0211 N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide;N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamideKY02111;KY02111, >=98%
- Categories:
-
CAS No:
Description
KY02111 is a small molecule which can promote differentiation of hPSCs to cardiomyocytes.IC50 value: Target: Wnt signaling inhibitorKY02111 Induces downregulation of Wnt signaling target genes; inhibits canonical Wnt signaling in a manner distinct from other known Wnt inhibitors.KY02111 (10 μM) increases the ratio of beating cardiac colonies as much as 70%-94% in cell aggregates of two hESC lines (KhES-1 and KhES-3), four hiPSC lines (253G1, IMR90-1, IMR90-4, and RCHIPC0003), and a mouse
Characteristics
88.7
4.3
white to beige
1.362±0.06 g/cm3(Predicted)
1.661
DMSO: soluble10mg/mL, clear
2-8°C
Safety Information
NONH for all modes of transport
3
22
46
Xn
P264, P270, P301+P312, P330, P501
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 127 companies from 1 notifications to the ECHA C&L Inventory.
Computed Properties
Molecular Weight:376.9
XLogP3:4.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:6
Exact Mass:376.0648413
Monoisotopic Mass:376.0648413
Topological Polar Surface Area:88.7
Heavy Atom Count:25
Complexity:456
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of KY0211
-
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates -
CN
2 YRS
Business licensed Certified factoryManufactory Supplier of 4-(Pentafluorothio)aniline,Pentafluoro,Pentafluorothio,Pentafluorosulfur,[4-(bromomethyl)phenyl]-pentafluoro-lambda6-sulfane,[4-(pentafluoro-sulfanyl)phenyl]acetic acidInquiryCAS No.: 1118807-13-8Grade: Industrial GradeContent: 95%
Latest News on KY0211
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4